Cargando…

Factors in rural community buprenorphine dispensing

BACKGROUND: There are pharmacy-related barriers to the dispensing of buprenorphine for the treatment of opioid use disorders. These include pharmacists' moral objections and mistrust of treatment regimens; the perception of a limit on the amount of buprenorphine able to be ordered and dispensed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Major, Erin G., Wilson, Courtenay Gilmore, Carpenter, Delesha M., Harless, J. Chase, Marley, Grace Trull, Ostrach, Bayla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871294/ https://www.ncbi.nlm.nih.gov/pubmed/36703716 http://dx.doi.org/10.1016/j.rcsop.2022.100204

Ejemplares similares

Rural community pharmacist willingness to dispense Suboxone® - A secret shopper investigation in South-Central Appalachia
por: Trull, Grace, et al.
Publicado: (2021)

North Carolina pharmacists’ willingness to sell fentanyl test strips: a survey study
por: Marley, Grace T., et al.
Publicado: (2023)

A content review of buprenorphine training programs for pharmacists
por: Davis, Scott A., et al.
Publicado: (2022)

“I’ll tell you what’s important to me…”: lessons for women’s health screening
por: Ostrach, Bayla M. M.
Publicado: (2021)

Medicaid prescription limits and their implications for naloxone accessibility
por: Roberts, Andrew W., et al.
Publicado: (2021)

“The elephant in the room;” a qualitative study of perinatal fears in opioid use disorder treatment in Southern Appalachia
por: Leiner, Catherine, et al.
Publicado: (2021)

Exploring community members' perceptions to adopt a Tele-COPD program in rural counties
por: Alexander, Dayna S., et al.
Publicado: (2021)

Buprenorphine Dispensing in Pennsylvania During the COVID-19 Pandemic, January to October 2020
por: Chalasani, Rohan, et al.
Publicado: (2021)

Rural community pharmacies’ preparedness for and responses to COVID-19
por: Carpenter, Delesha M., et al.
Publicado: (2021)

“They don’t go by the law around here”: law enforcement interactions after the legalization of syringe services programs in North Carolina
por: Morrissey, Brandon, et al.
Publicado: (2022)

Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
por: Oakley, Bridget, et al.
Publicado: (2021)

Patterns of GP and nurse independent prescriber prescriptions for antibiotics dispensed in the community in England: a retrospective analysis
por: Courtenay, Molly, et al.
Publicado: (2023)

COVID-19 booster vaccination in rural community pharmacies
por: Gamble, Abigail, et al.
Publicado: (2023)

O02 Patterns of GP and nurse-independent prescriber prescriptions for antibiotics dispensed in the community in England: a retrospective analysis
por: Courtenay, Molly, et al.
Publicado: (2023)

Rural community pharmacists’ ability and interest in administering COVID-19 vaccines in the Southern United States
por: Carpenter, Delesha M., et al.
Publicado: (2022)

Associations between implementation of Project Lazarus and opioid analgesic dispensing and buprenorphine utilization in North Carolina, 2009–2014
por: Alexandridis, Apostolos A., et al.
Publicado: (2019)

We all have a role to play in suicide prevention
por: Carpenter, Delesha
Publicado: (2022)

Measuring patient perspectives on community pharmacy quality: psychometric evaluation of a brief survey
por: Carpenter, Delesha M, et al.
Publicado: (2021)

Community Treatment Programs Take Up Buprenorphine
por: Casadonte, Paul P., et al.
Publicado: (2004)

Buprenorphine
por: Mazurek, Jaroslaw, et al.
Publicado: (2014)

Psychological safety and accountability in longitudinal integrated clerkships: a dual institution qualitative study
por: Latessa, Robyn A., et al.
Publicado: (2023)

Lessons learned recruiting a diverse sample of rural study participants during the COVID-19 pandemic
por: Kim, Nam Hyo, et al.
Publicado: (2021)

Trends in pharmacy-based dispensing of buprenorphine, extended-release naltrexone, and naloxone during the COVID-19 pandemic by age and sex – United States, March 2019 – December 2020
por: Cremer, Laura J., et al.
Publicado: (2022)

Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder
por: Weintraub, Eric, et al.
Publicado: (2021)

Community Pharmacy Enhanced Dispensing Model to Improve Medication Access for Rural Patients Living with HIV
por: Burde, Anushka, et al.
Publicado: (2019)

Trends in Out-of-Pocket Costs for and Characteristics of Pharmacy-Dispensed Buprenorphine Medications for Opioid Use Disorder Treatment by Type of Payer, 2015 to 2020
por: Strahan, Andrea E., et al.
Publicado: (2023)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018)

Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population
por: Jumah, Naana Afua, et al.
Publicado: (2016)

Rural and urban differences in undersupply of buprenorphine provider availability in the United States, 2018
por: Conway, Kevin P., et al.
Publicado: (2022)

Advancing emergency department–initiated buprenorphine
por: Huntley, Kristen, et al.
Publicado: (2021)

Development and evaluation of a community-based buprenorphine treatment intervention
por: Fox, Aaron D., et al.
Publicado: (2017)

Treatment retention in opioid agonist therapy: comparison of methadone versus buprenorphine/naloxone by analysis of daily-witnessed dispensed medication in a Canadian Province
por: Sadek, Joseph, et al.
Publicado: (2022)

A needs assessment for suicide prevention training within community pharmacies
por: O'Driscoll, Michelle, et al.
Publicado: (2023)

Technology-Assisted Buprenorphine Treatment in Rural and Nonrural Settings: Two Randomized Clinical Trials
por: Sigmon, Stacey C., et al.
Publicado: (2023)

Changing the Course of the Next 40 Years: Time to Address Rampant Inhaler Misuse Using System-Level Educational Solutions
por: Press, Valerie G., et al.
Publicado: (2019)

BUPRENORPHINE WITHDRAWAL SYNDROME
por: Tripathi, B.M., et al.
Publicado: (1995)

Comparison of spinal block after intrathecal clonidine–bupivacaine, buprenorphine–bupivacaine and bupivacaine alone in lower limb surgeries
por: Arora, Major Vishal, et al.
Publicado: (2016)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
por: Kanervo, Minna M., et al.
Publicado: (2022)

Case Report: Buprenorphine-precipitated fentanyl withdrawal treated with high-dose buprenorphine
por: Bormann, Nicholas L., et al.
Publicado: (2023)

State policy influence on the early diffusion of buprenorphine in community treatment programs
por: Ducharme, Lori J, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ttn4sv81gnnidd586l2as7l8s9